Specifically, the osteogenic marker BMP-2 (Fig. 10a) was expressed at particularly low levels in mSGSCs cultured with CCM at p.2 and p.6, with a slight increase to p.10 (p < 0.05). This evidence concerns the gene BMP2 and cerebral cavernous malformation.